Vinnytsia, Ukraine Clinical Trials

A listing of Vinnytsia, Ukraine clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 4 clinical trials
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus

This is a first exploration of GLPG3970 in subjects with active systemic lupus erythematosus (SLE) to evaluate the effect on disease biomarkers and to determine its pharmacokinetics (PK) profile, safety and tolerability, and pharmacodynamics (PD) biomarkers related to the investigational product (IP) mechanism of action and the pathophysiology of SLE.

SRI of Invalid Rehabilitation
 (3.0 away) Contact site
  • 24 May, 2021
  • +9 other locations
A Phase 1 Study of INCMGA00012 in Patients With Advanced Solid Tumors

The primary goal of this Phase 1 study is to characterize the safety and tolerability of INCMGA00012 and establish the maximum tolerated dose (MTD) of INCMGA00012 administered on either every two week or every four week schedules of administration among patients with solid tumors. Pharmacokinetics, pharmacodynamics, and the anti-tumor activity …

Regional Clinical Oncology Center, Department of Chemotherapy in the facility of State Higher Educational Institution
 (170.7 away) Contact site
  • 26 Jan, 2021
  • +119 other locations
A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

The primary goal of this Phase 1 study is to characterize the safety and tolerability of MGD013 and establish the maximum tolerated dose (MTD) of MGD013. Pharmacokinetics (PK), immunogenicity, pharmacodynamics (PD), and the anti-tumor activity of MGD013 will also be assessed.

solid tumour
measurable disease
Communal Nonprofit Enterprise Podillia Regional Center of Oncology of Vinniza Regional Council
 (3.0 away) Contact site
  • 17 Feb, 2021
  • +69 other locations
A Study to Test Different Doses of BI 836880 Combined With BI 754091 in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours

This study has 2 parts. The first part is open to adults with advanced non-small cell lung cancer. The second part is open also to adults with other types of advanced cancer of the lung, brain, skin, and liver. The participants get a combination of two medicines called BI 836880 …

cancer treatment
platinum-based chemotherapy
antineoplastic agents
glioblastoma multiforme
lung cancer
Kyiv City Clinical Oncological Center
 (123.8 away) Contact site
  • 20 Jun, 2021
  • +62 other locations